Schematic representation of the SARS-CoV-2 structure.

CV4002: SARS 3CL Protease Antibody


Out of stock please call for lead time


Within the last two decades, SARS and MERS coronaviruses emerged as global health concerns causing severe acute respiratory syndromes. In December 2019, a novel coronavirus (SARS-CoV-2) was identified in Wuhan, Hubei province in China. The SARS-CoV genome encodes several non-structural proteins that are essential for the life cycle of the virus. The viral 3-chymotrypsin-like cysteine protease (3CL-PRO) enzyme controls coronavirus replication. 3CL-PRO is a proven drug discovery target in the case of SARS-CoV and MERS-CoV. Since the genome sequence of SARS-CoV-2 is very similar to that of SARS-CoV, inhibition of 3CL-PRO activity represents a viable strategy at the basis of a COVID-19 therapy. The SARS 3CL-PRO Protein Antibody recognizes and binds to both SARS-CoV and SARS-CoV-2 3CL-PRO enzymes.


Host Rabbit
Quantity 100 µg
Concentration Variable
Storage Store at -20°C. Avoid freeze/thaw cycles..


There are no reviews yet.

Be the first to review “CV4002: SARS 3CL Protease Antibody”


  • Detection of 3CL Protease by Western blot
  • Detection of 3CL Protease by ELISA
  • Detection of  3CL Protease in Serum Samples